Cargando…

Policies and Problems of Modernizing Ethnomedicine in China: A Focus on the Yi and Dai Traditional Medicines of Yunnan Province

Yunnan is a multiethnic province in southwest China, rich in Materia medica resources, and is popularly known as the kingdom of plants. Biomedicine and public health industry have been the industrial pillars of Yunnan since 2016, which is the important pharmaceutical industrial base for Dai and Yi m...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Zhiyong, Li, Caifeng, Zhang, Xiaobo, Tang, Shihuan, Yang, Hongjun, Cui, Xiuming, Huang, Luqi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443223/
https://www.ncbi.nlm.nih.gov/pubmed/32855645
http://dx.doi.org/10.1155/2020/1023297
_version_ 1783573590702030848
author Li, Zhiyong
Li, Caifeng
Zhang, Xiaobo
Tang, Shihuan
Yang, Hongjun
Cui, Xiuming
Huang, Luqi
author_facet Li, Zhiyong
Li, Caifeng
Zhang, Xiaobo
Tang, Shihuan
Yang, Hongjun
Cui, Xiuming
Huang, Luqi
author_sort Li, Zhiyong
collection PubMed
description Yunnan is a multiethnic province in southwest China, rich in Materia medica resources, and is popularly known as the kingdom of plants. Biomedicine and public health industry have been the industrial pillars of Yunnan since 2016, which is the important pharmaceutical industrial base for Dai and Yi medicine in China. This review of the Yunnan ethnic medicine industry describes some of the problems to be solved in the development of sustainable ethnomedicine in China. We investigated Chinese patent medicines (CPMs) declared as ethnomedicine on the drug instructions and identified 28 Dai patent medicines (DPMs) and 73 Yi patent medicines (YPMs) that were approved for clinical use in China. In further research, the clinical indications of these CPMs were determined, and the quality standard of medicinal materials and their usage frequencies in DPMs and YPMs were investigated. We also collected and analyzed the data on use of botanical and animal sources of medicines, the rare and endangered medicinal materials, and toxic medicines in DPMs and YPMs. The application of zootherapy in Yi traditional medicine was introduced from its abundant ancient documents and records; based on the “YaGei” theory in Dai traditional medicine, toxic medicines can be relatively safe in DPMs. However, for promoting the Yunnan traditional medicine industry, it is necessary to strengthen medical research to expand evidence-based clinical practice and balance ethnomedicine production and sustainable utilization of Materia medica resources, especially the animal sources of medicines, toxic medicines, and the protected wild resources reported in this survey. Only in this way can industrialization of ethnomedicine promote the improvement of human health.
format Online
Article
Text
id pubmed-7443223
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-74432232020-08-26 Policies and Problems of Modernizing Ethnomedicine in China: A Focus on the Yi and Dai Traditional Medicines of Yunnan Province Li, Zhiyong Li, Caifeng Zhang, Xiaobo Tang, Shihuan Yang, Hongjun Cui, Xiuming Huang, Luqi Evid Based Complement Alternat Med Review Article Yunnan is a multiethnic province in southwest China, rich in Materia medica resources, and is popularly known as the kingdom of plants. Biomedicine and public health industry have been the industrial pillars of Yunnan since 2016, which is the important pharmaceutical industrial base for Dai and Yi medicine in China. This review of the Yunnan ethnic medicine industry describes some of the problems to be solved in the development of sustainable ethnomedicine in China. We investigated Chinese patent medicines (CPMs) declared as ethnomedicine on the drug instructions and identified 28 Dai patent medicines (DPMs) and 73 Yi patent medicines (YPMs) that were approved for clinical use in China. In further research, the clinical indications of these CPMs were determined, and the quality standard of medicinal materials and their usage frequencies in DPMs and YPMs were investigated. We also collected and analyzed the data on use of botanical and animal sources of medicines, the rare and endangered medicinal materials, and toxic medicines in DPMs and YPMs. The application of zootherapy in Yi traditional medicine was introduced from its abundant ancient documents and records; based on the “YaGei” theory in Dai traditional medicine, toxic medicines can be relatively safe in DPMs. However, for promoting the Yunnan traditional medicine industry, it is necessary to strengthen medical research to expand evidence-based clinical practice and balance ethnomedicine production and sustainable utilization of Materia medica resources, especially the animal sources of medicines, toxic medicines, and the protected wild resources reported in this survey. Only in this way can industrialization of ethnomedicine promote the improvement of human health. Hindawi 2020-08-14 /pmc/articles/PMC7443223/ /pubmed/32855645 http://dx.doi.org/10.1155/2020/1023297 Text en Copyright © 2020 Zhiyong Li et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Li, Zhiyong
Li, Caifeng
Zhang, Xiaobo
Tang, Shihuan
Yang, Hongjun
Cui, Xiuming
Huang, Luqi
Policies and Problems of Modernizing Ethnomedicine in China: A Focus on the Yi and Dai Traditional Medicines of Yunnan Province
title Policies and Problems of Modernizing Ethnomedicine in China: A Focus on the Yi and Dai Traditional Medicines of Yunnan Province
title_full Policies and Problems of Modernizing Ethnomedicine in China: A Focus on the Yi and Dai Traditional Medicines of Yunnan Province
title_fullStr Policies and Problems of Modernizing Ethnomedicine in China: A Focus on the Yi and Dai Traditional Medicines of Yunnan Province
title_full_unstemmed Policies and Problems of Modernizing Ethnomedicine in China: A Focus on the Yi and Dai Traditional Medicines of Yunnan Province
title_short Policies and Problems of Modernizing Ethnomedicine in China: A Focus on the Yi and Dai Traditional Medicines of Yunnan Province
title_sort policies and problems of modernizing ethnomedicine in china: a focus on the yi and dai traditional medicines of yunnan province
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7443223/
https://www.ncbi.nlm.nih.gov/pubmed/32855645
http://dx.doi.org/10.1155/2020/1023297
work_keys_str_mv AT lizhiyong policiesandproblemsofmodernizingethnomedicineinchinaafocusontheyianddaitraditionalmedicinesofyunnanprovince
AT licaifeng policiesandproblemsofmodernizingethnomedicineinchinaafocusontheyianddaitraditionalmedicinesofyunnanprovince
AT zhangxiaobo policiesandproblemsofmodernizingethnomedicineinchinaafocusontheyianddaitraditionalmedicinesofyunnanprovince
AT tangshihuan policiesandproblemsofmodernizingethnomedicineinchinaafocusontheyianddaitraditionalmedicinesofyunnanprovince
AT yanghongjun policiesandproblemsofmodernizingethnomedicineinchinaafocusontheyianddaitraditionalmedicinesofyunnanprovince
AT cuixiuming policiesandproblemsofmodernizingethnomedicineinchinaafocusontheyianddaitraditionalmedicinesofyunnanprovince
AT huangluqi policiesandproblemsofmodernizingethnomedicineinchinaafocusontheyianddaitraditionalmedicinesofyunnanprovince